Biologics Control Act
The Biologics Control Act, established in 1902, is a U.S. law that regulates the safety and effectiveness of biological products, which include vaccines, blood products, and other medical treatments derived from living organisms. It was created to protect public health by ensuring that these products are safe, pure, and potent before they reach consumers. The law requires rigorous testing and approval processes by the Food and Drug Administration (FDA) to help prevent dangerous or ineffective treatments from being used in healthcare.
Additional Insights
-
The Biologics Control Act of 1902 was a landmark U.S. law aimed at regulating biological products, such as vaccines and blood serums, to ensure their safety, effectiveness, and quality. This law arose in response to public health crises caused by contaminated products, notably a deadly smallpox vaccine. It established pre-market approval processes, requiring rigorous testing and oversight by federal authorities. Ultimately, the act aimed to protect patients from dangerous or ineffective biological treatments and laid the groundwork for modern regulations governing health products, contributing to advancements in medical safety and public health.